Because of its role as an intracellular transporter of gemcitabine, hENT1 has been examined as a candidate cancer biomarker, particularly in pancreatic cancer [8, 9, 15–19]. The gene discussed is SLC29A1; the disease is familial pancreatic carcinoma.